ophthalmology
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The non-invasive eye examination is also used to identify conditions such as diabetic neuropathy, Parkinson’s disease, multiple sclerosis, and dementia.
Funding will be used to push for regulatory approval of its flagship synthetic implant product.
Pr3vent's non-invasive tool looks to catch ophthalmic conditions when kids are still young.